M. Tsolaki

Discipline

Psychologie (8)

Type de document

Articles (15)

Co-auteur

Date

Source

Mot-clé

Alzheimer's disease (14) Amyloid (13) Biochemical markers (11) âge (10) Human beings (10) Age (10) Age (10) biomarqueur (9) Proteins (8) pathologie (7) maladie (7) Apolipoprotein E (7) Weights and measures (7) Pathology (7) Cerebrospinal fluid (7) maladie (7) protéine (6) Dementia (6) Cognition (6) Brain (6) Older people (6) Mild cognitive impairment (6) Proteomics (6) plasma (6) cohorte (6) cerveau (6) information (5) Patients (5) Patients (5) risque (4)

Documents écrit par M. Tsolaki (15) | parle de M. Tsolaki (0)

Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits.
F. Küçükali et al.
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.
A. Delvenne et al. (14 juin 2022)
CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals.
B.M. Tijms et al. (2 août 2021)
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.
I. de Rojas et al. (7 juin 2021)
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
B.M. Tijms et al. (1 déc. 2020)
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease.
E. Konijnenberg et al. (27 mai 2020)
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
S. Westwood et al. (2020)
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.
L. Shi et al. (2020)
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
L. Shi et al.
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
M. Kim et al.
Inflammatory biomarkers in Alzheimer's disease plasma.
A.R. Morgan et al.
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort.
D. Stamate et al. (2019)
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.
M. Ten Kate et al. (27 sept. 2018)
Analysis of shared heritability in common disorders of the brain.
V. Anttila et al. (22 juin 2018)
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
W.J. Jansen et al. (2015)